Women In Cannabis Study: Launch – Chapter 3 – Why Work in Cannabis?

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Related Posts

Cannara Biotech Reports Record Growth in Fiscal 2024
MAPS Wins FDA Approval for Clinical Trials of Medical Cannabis
Curaleaf Secures Massachusetts’ First Cannabis Research License
Blunt Brunch Nationals: A Night of Glitz and Glam Celebrates Women in Cannabis
AFC Gamma (AFCG) Set to Announce Quarterly Earnings

Latest News

  • Fast Buds - German cannabis legalisation

Germany’s Cannabis Legislation Faces Criticism

November 27th, 2024|

LOS ANGELES- Germany's recent legalization of cannabis has encountered significant criticism from various stakeholders, highlighting challenges in its implementation and effectiveness. Criticism from Berlin's Justice Senator Felor Badenberg, Berlin's Justice Senator, has expressed concerns that ...

Cannara Biotech Reports Record Growth in Fiscal 2024

November 27th, 2024|

LOS ANGELES- Montreal-based Cannara Biotech Inc a vertically integrated cannabis producer, announced record-breaking financial results for its fiscal year ended August 31, 2024. The company reported total annual revenues of $82.2 million, a 43% increase ...